Eyebright Medical Technology (Beijing) Co., Ltd.

SHSE:688050 주식 보고서

시가총액: CN¥16.3b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Eyebright Medical Technology (Beijing) 관리

관리 기준 확인 4/4

Eyebright Medical Technology (Beijing)'s CEO는 Jiangbing Xie, Jun2019 에 임명되었습니다 의 임기는 5.08 년입니다. 는 CN¥ 1.67B 가치에 해당하는 회사 주식의 12.93% 직접 소유합니다. 1.67B. 경영진과 이사회의 평균 재임 기간은 각각 3.6 년과 4.7 년입니다.

주요 정보

Jiangbing Xie

최고 경영자

CN¥1.3m

총 보상

CEO 급여 비율n/a
CEO 임기5.3yrs
CEO 소유권12.9%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간4.9yrs

최근 관리 업데이트

Recent updates

Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 23
Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)

Jul 15
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)

Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings

Jun 10
Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings

Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

May 13
Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Apr 24
Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Apr 21
Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Mar 25
Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Mar 18
A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

Mar 01
Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

CEO

Jiangbing Xie (52 yo)

5.3yrs

테뉴어

CN¥1,321,800

보상

Mr. Jiangbing Xie serves as Chairman of the Board and General Manager at Eyebright Medical Technology (Beijing) Co., Ltd. since June 2019 and is its Chief Scientist.


리더십 팀

이름위치테뉴어보상소유권
Jiangbing Xie
Chairman of the Board5.3yrsCN¥1.32m12.92%
CN¥ 2.1b
Baoshan Jia
Deputy GM & National Marketing Director5.3yrsCN¥1.61m0.0036%
CN¥ 583.8k
Zhao Wang
Deputy GM2.3yrsCN¥894.60k0.0042%
CN¥ 686.2k
Yuqian Zhou
Assistant to the GM & Board Secretary2.3yrsCN¥567.30k0.0064%
CN¥ 1.0m

3.8yrs

평균 재임 기간

44yo

평균 연령

경험이 풍부한 관리: 688050 의 관리팀은 경험 ( 3.6 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Jiangbing Xie
Chairman of the Board5.3yrsCN¥1.32m12.92%
CN¥ 2.1b
Zhao Wang
Deputy GM4.5yrsCN¥894.60k0.0042%
CN¥ 686.2k
Fang Yu
Director5.3yrs데이터 없음데이터 없음
Haiyan Wang
Independent Director5.3yrsCN¥160.00k데이터 없음
Feng Jiang
Independent Director2.7yrsCN¥160.00k데이터 없음
Yu Jiao Wang
Employee Supervisor5.3yrs데이터 없음데이터 없음
Yong Chen
Director2.3yrs데이터 없음데이터 없음
Lin Liang
Supervisor2.3yrs데이터 없음데이터 없음

4.9yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 이사회: 688050 의 이사회경험(평균 재직 기간 5 년)으로 간주됩니다.